An analysis of AFP-L3%, a fraction of AFP binding to LCA, appears to be a better biomarker for identifying a recurrence of the yolk sac tumour than an analysis of AFP in serum for a neo-natal patient [116]. Here, AFP is linked to yolk sac tumor.